BAUSCH HEALTH COS INCBHC
ASignal's systematic analysis rates BHC as Neutral.
Reflects the latest available analysis · analyzed Oct 30, 2026
The case on BHC
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong technical momentum with RSI above 90 and MACD above signal line
- Price trading significantly above Bollinger Bands, indicating strong upward momentum
- High gross margin of 72.62% indicating pricing power
- Strong year-over-year earnings growth of 139.6%
- Positive free cash flow of $1.64B
- Extremely overbought RSI at 90.42, increasing risk of pullback
- Negative price-to-book ratio (-2.51x) suggesting accounting insolvency or large intangible assets
- Return on equity at -11040%, indicating severe fundamental distortion
- Lack of Reddit mentions, suggesting low retail investor interest
- Forward P/E of 2.08x may indicate unsustainable earnings expectations
See the full verdict on BHC
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes BHC
Most investors never get a second opinion, let alone several. ASignal runs BHC past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.